Department of Tissue Engineering, Faculty of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Department of Radiotherapy Oncology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Asian Pac J Cancer Prev. 2022 Feb 1;23(2):731-741. doi: 10.31557/APJCP.2022.23.2.731.
Breast Cancer (BC) is a malignancy with high mortality among women. Recently, scaffold-based three-dimensional (3D) models have been developed for anti-cancer drug research. The present study aimed to investigate the anti-proliferative effects of Astragalus hamosus (A. hamosus) in 3D fibrin gel against MCF-7 cell line. We have also evaluated anti-proliferative effect of A. hamosus differences between 3D and 2D cultures.
The fibrin gel formulation was first optimized by testing the structural and mechanical properties. Then the cytotoxic effect of A. hamosus extract was assessed on MCF-7 cells by MTT assay. Cell apoptosis was evaluated using TUNEL method and flow cytometry. Cell cycle and proliferation were analyzed by flow cytometry. Apoptosis-related gene expression such as Bcl-2, caspase-3, -8 and -9 were quantified by real time-PCR.
TUNEL staining showed a significant damage accompanied with cell apoptosis. Flow cytometry analysis revealed that apoptosis increased after treatment with A. hamosus extract in 3D culture model compared to 2D culture. The A. hamosus extract arrested cell cycle in the S and G2/M phases in 3D model while in the 2D culture G0/G1 phase was affected. Treatment with A. hamosus extract led to upregulation of the caspase-3, -8 and -9 genes and downregulation of the Ki-67 in the 3D-culture compared with the 2D culture.
These results indicated that A. hamosus extract could be used as a therapeutic candidate for BC due to its anti-proliferative effects. Furthermore, 3D fibrin gel could be better than 2D-cultured cells in simulating important tumor characteristics in vivo, namely, anti-proliferative and anti-apoptotic features.
乳腺癌(BC)是一种女性死亡率较高的恶性肿瘤。最近,已经开发出基于支架的三维(3D)模型来进行抗癌药物研究。本研究旨在研究黄芪(A. hamosus)在 3D 纤维蛋白凝胶中的抗增殖作用对 MCF-7 细胞系的影响。我们还评估了 3D 和 2D 培养之间 A. hamosus 抗增殖作用的差异。
首先通过测试结构和机械性能来优化纤维蛋白凝胶配方。然后通过 MTT 测定法评估 A. hamosus 提取物对 MCF-7 细胞的细胞毒性作用。使用 TUNEL 法和流式细胞术评估细胞凋亡。通过流式细胞术分析细胞周期和增殖。通过实时 PCR 定量测定凋亡相关基因表达,如 Bcl-2、caspase-3、-8 和 -9。
TUNEL 染色显示出明显的损伤伴随着细胞凋亡。流式细胞术分析显示,与 2D 培养相比,3D 培养模型中 A. hamosus 提取物处理后细胞凋亡增加。A. hamosus 提取物在 3D 模型中使细胞周期停滞在 S 和 G2/M 期,而在 2D 培养中则影响 G0/G1 期。与 2D 培养相比,A. hamosus 提取物处理导致 3D 培养中 caspase-3、-8 和 -9 基因上调,Ki-67 下调。
这些结果表明,由于其抗增殖作用,A. hamosus 提取物可作为 BC 的治疗候选药物。此外,3D 纤维蛋白凝胶在模拟体内重要肿瘤特征方面可能优于 2D 培养细胞,即抗增殖和抗凋亡特征。